The Good, The Bad, And The Uncertain: Trump’s Second Administration And The Rx Industry

 
• By Nielsen Hobbs
  
With Trump’s return, pharma trades a disagreeable White House for an unpredictable one. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Elections

More from Legislation